View on Pubmed.gov 35281829 | View on doi.org 10.3389/fgene.2...
ARZIMM: A Novel Analytic Platform for the Inference of Microbial Interactions and Community Stability from Longitudinal Microbiome Study.
- Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States.
- Division of Biostatistics, Department of Population Health, New York University School of Medicine, East Hanover, NY, United States.
- Center for Advanced Biotechnology and Medicine, Rutgers University, New Brunswick, NJ, United States.
- Division of Intramural Research, Immunopathogenesis Section, NIAID, NIH, Bethesda, MD, United States.
Abstract
Dynamic changes of microbiome communities may play important roles in human health and diseases. The recent rise in longitudinal microbiome studies calls for statistical methods that can model the temporal dynamic patterns and simultaneously quantify the microbial interactions and community stability. Here, we propose a novel autoregressive zero-inflated mixed-effects model (ARZIMM) to capture the sparse microbial interactions and estimate the community stability. ARZIMM employs a zero-inflated Poisson autoregressive model to model the excessive zero abundances and the non-zero abundances separately, a random effect to investigate the underlining dynamic pattern shared within the group, and a Lasso-type penalty to capture and estimate the sparse microbial interactions. Based on the estimated microbial interaction matrix, we further derive the estimate of community stability, and identify the core dynamic patterns through network inference. Through extensive simulation studies and real data analyses we evaluate ARZIMM in comparison with the other methods.
References
Nat Rev Microbiol. 2012 Jul 16;10(8):538-50
J Med Microbiol. 2006 May;55(Pt 5):625-633
Front Microbiol. 2017 Nov 15;8:2224
Clin Microbiol Infect. 2008 Oct;14(10):908-34
Cited by 4 citations (total)
Journal Article
Identifying stationary microbial interaction networks based on irregularly spaced longitudinal 16S rRNA gene sequencing data.
Electronic publication date January 1, 2024
Jie Zhou [...] Anne G Hoen et al.
Introduction
The microbial interactions within the human microbiome are complex, and few methods are available to identify these interactions within a...
Journal Article Preprint
Gut microbiota phospholipids regulate intestinal gene expression and can counteract the effects of antibiotic treatment.
Electronic publication date February 20, 2025
Xue-Song Zhang [...] Martin J Blaser et al.
The gut microbiome influences immune and metabolic homeostasis. Our research using non-obese diabetic (NOD) mice revealed that early-life antibiotic exposure...
Conflict of interest statement
LH was employed by the company Novartis Pharmaceuticals Corporation. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
MeSH
Specialties
Copyright
Copyright © 2022 He, Wang, Hu, Gao, Falcone, Holland, Blaser and Li.